Gf Fund Management Co. Ltd. Denali Therapeutics Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.26 Trillion
- Q1 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 3,685 shares of DNLI stock, worth $51,184. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,685
Previous 3,022
21.94%
Holding current value
$51,184
Previous $61.6 Million
18.66%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding DNLI
# of Institutions
234Shares Held
127MCall Options Held
37.3KPut Options Held
7.9K-
Black Rock Inc. New York, NY13.2MShares$183 Million0.01% of portfolio
-
Baillie Gifford & CO12.1MShares$168 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$164 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA11.4MShares$158 Million0.03% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL6.77MShares$94 Million0.02% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $1.86B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...